Literature DB >> 15981585

A novel rhodamine-riboflavin conjugate probe exhibits distinct fluorescence resonance energy transfer that enables riboflavin trafficking and subcellular localization studies.

Mitch A Phelps1, Amy B Foraker, Wenqing Gao, James T Dalton, Peter W Swaan.   

Abstract

Riboflavin (vitamin B2, RF) is taken up in eukaryotic cells via specialized transport mechanisms. Although RF has fluorescence properties, direct microscopic visualization of RF uptake and trafficking has been complicated by cellular autofluorescence. We describe the synthesis, cellular uptake characteristics, and spectroscopic properties of a novel rhodamine-riboflavin conjugate (RD-RF), including absorption and emission spectra, two-photon excitation spectra, and fluorescence pH dependence. The conjugate has a molar extinction coefficient of 23 670 M(-1) cm(-1) at 545 nm (excitation wavelength) with a fluorescence quantum yield of 0.94. This compound exhibits intramolecular fluorescence resonance energy transfer (FRET). Selective quenching of the FRET signal is observed when RD-RF is bound with high affinity by the chicken riboflavin carrier protein. In addition to the typical rhodamine excitation and emission, FRET provides a secondary signal for conjugate localization and an in situ mechanism for observing riboflavin binding. Solution and in vitro stability determinations indicate that the linkage between riboflavin and rhodamine is stable for the duration of typical pulse--chase and cellular trafficking experiments. The distinct spectroscopic properties of RD-RF together with a comparable affinity for RF-binding proteins render it an excellent tool for the study of RF transport and trafficking in living cells.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15981585     DOI: 10.1021/mp0499510

Source DB:  PubMed          Journal:  Mol Pharm        ISSN: 1543-8384            Impact factor:   4.939


  7 in total

1.  Visible light and near-infrared-responsive chromophores for drug delivery-on-demand applications.

Authors:  Chase S Linsley; Viola Y Quach; Gaurav Agrawal; Elyse Hartnett; Benjamin M Wu
Journal:  Drug Deliv Transl Res       Date:  2015-12       Impact factor: 4.617

2.  cAMP-Coupled riboflavin trafficking in placental trophoblasts: a dynamic and ordered process.

Authors:  Vanessa M D'Souza; Amy B Foraker; R Benjamin Free; Abhijit Ray; Paul S Shapiro; Peter W Swaan
Journal:  Biochemistry       Date:  2006-05-16       Impact factor: 3.162

3.  Pharmacokinetics, lymph node uptake, and mechanistic PK model of near-infrared dye-labeled bevacizumab after IV and SC administration in mice.

Authors:  Fang Wu; Mitalee Tamhane; Marilyn E Morris
Journal:  AAPS J       Date:  2012-03-06       Impact factor: 4.009

Review 4.  The subcellular distribution of small molecules: from pharmacokinetics to synthetic biology.

Authors:  Nan Zheng; Hobart Ng Tsai; Xinyuan Zhang; Gus R Rosania
Journal:  Mol Pharm       Date:  2011-08-15       Impact factor: 4.939

5.  Bioanalytical Screening of Riboflavin Antagonists for Targeted Drug Delivery - A Thermodynamic and Kinetic Study.

Authors:  Anna Plantinga; Amanda Witte; Ming-Hsin Li; Andrew Harmon; Seok Ki Choi; Mark M Banaszak Holl; Bradford G Orr; James R Baker; Kumar Sinniah
Journal:  ACS Med Chem Lett       Date:  2011-05-12       Impact factor: 4.345

6.  LL-37 peptide enhancement of signal transduction by Toll-like receptor 3 is regulated by pH: identification of a peptide antagonist of LL-37.

Authors:  Divyendu Singh; Robert Vaughan; C Cheng Kao
Journal:  J Biol Chem       Date:  2014-08-04       Impact factor: 5.157

7.  Riboflavin-targeted polymer conjugates for breast tumor delivery.

Authors:  Lisa M Bareford; Brittany R Avaritt; Hamidreza Ghandehari; Anjan Nan; Peter W Swaan
Journal:  Pharm Res       Date:  2013-04-09       Impact factor: 4.200

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.